Enanta sues Pfizer, demanding compensation for Paxlovid-related patent infringement

Pfizer is seeing an uptick in litigation related to its mega-blockbuster Covid-19 vaccine and therapeutic, with the latest suit coming from Massachusetts-based Enanta Pharmaceuticals. Enanta on Wednesday filed suit against Pfizer in district court in Massachusetts, seeking damages for infringement on a patent it originally filed back in July 2020.…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.